This site is intended for US healthcare professionals only. Visit Patient Site

WHAT IS OVERACTIVE BLADDER (OAB)?

OAB happens when your bladder muscles suddenly contract too frequently and too often, even when your bladder isn't full, creating an urgent feeling that you need to urinate.

What are the symptoms of OAB?

  • Urge urinary incontinence (leakage episodes): when urine leaks from the bladder uncontrollably
  • Urgency: a sudden need to urinate even when the bladder isn't full
  • Frequency: the frequent urge to urinate (more than 8 times per day)

There are many misperceptions about OAB that may delay people like you from seeking treatment. Learn more about what to look for below and find out how a treatment option may help with disruptive OAB symptoms.

What OAB isn't

  • Something you always have to cope with on your own
  • A condition that always requires surgery for treatment
  • Treatable through lifestyle changes alone in some cases
  • Just a normal part of being a woman
  • Just a normal result of getting older

Overactive bladder is more common than you think—you are not alone

Many people think OAB is an acceptable part of aging, but it doesn't have to be. You can do something about it.

US Map

Approximately 1 in 10 Americans are affected by bothersome overactive bladder symptoms

That's about 33 million people.

Listen to Kate, a patient with overactive bladder, talk about her symptoms

…the more women I talk to, the more I feel like I'm not alone.”

Kate, a real GEMTESA patient who has been compensated for her participation in this video

Transcript

For me overactive bladder, or OAB, has made me feel isolated and insecure.”

[Text on screen] More Than My OAB: Kate's GEMTESA Journey

The Impact of Overactive Bladder

Kate is a real patient taking GEMTESA who has been compensated by Urovant Sciences for her participation in this video.

I always felt that it was my dirty little secret and I was the only one dealing with this problem.

 

I dreaded going to the drugstore. When I would go there, I would tiptoe into the aisle where the pads were and then get to the checkout as fast as possible hoping that no one would see me. And then I thought to myself, at 64, this is what it's come to? I'm wearing pads? It was daunting. It was my new reality.

 

When I talk to women with my experience, I explain to them that you're not the only one that has this problem. I never realized that one out of ten people deal with this issue.

 

The sense of community has been amazing. It's helped me open up, and then the more women that I talk to, the more I feel like I'm not alone. And that's a great thing.”

[Text on screen] GEMTESA is a prescription medication for the treatment of overactive bladder (OAB) in adults with symptoms of leakage episodes, urgency, and frequency. Please see Important Safety Information at the end of this video.

I would tell people that there is help, that they don't have to struggle and be alone with this problem anymore. And for me, GEMTESA has been living proof of that.

 

Make that first step. Make that first step, go see a doctor, that's the important thing.”

[Text on screen] Starting the conversation is the first step to managing OAB.

Talk with a healthcare professional about GEMTESA today.

Do not take if you have a known allergic reaction to GEMTESA or its ingredients. Tell your doctor right away if you are unable to empty your bladder or if you have a weak urine stream.

[Text on screen] GEMTESA may increase your chances of not being able to empty your bladder.

Tell your doctor if you are taking medicines that contain digoxin, or if you have liver or kidney problems.

Side effects may include headache, common cold symptoms, diarrhea, nausea, urinary tract and upper respiratory tract infection.

[Text on screen] Available by prescription only. Call 1-833-UROVANT.

Full Product Information can be found at GEMTESA.com/PI

 

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

GEMTESA is contraindicated in patients with known hypersensitivity to vibegron or any components of the product.

WARNINGS AND PRECAUTIONS

Urinary Retention

Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of OAB. Discontinue GEMTESA in patients who develop urinary retention.

ADVERSE REACTIONS

Most common adverse reactions (2%) reported with GEMTESA were headache, urinary tract infection, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection.

 

INDICATIONS AND USAGE

GEMTESA® is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

GEMTESA is contraindicated in patients with known hypersensitivity to vibegron or any components of the product.

WARNINGS AND PRECAUTIONS

Urinary Retention

Urinary retention has been reported in patients taking GEMTESA. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of OAB. Discontinue GEMTESA in patients who develop urinary retention.

ADVERSE REACTIONS

Most common adverse reactions (2%) reported with GEMTESA were headache, urinary tract infection, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection.

Please see full Prescribing Information.

You are encouraged to report side effects and product complaints associated with GEMTESA by calling 1-833-876-8268.

Sumitomo Pharma logo.

is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO PHARMA is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO is a registered trademark of Sumitomo Chemical Co., Ltd., used under license. Sumitomo Pharma America, Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

GEMTESA, and the GEMTESA logo are trademarks of Urovant Sciences GmbH, registered in the U.S. and in other countries.

©2024 Sumitomo Pharma America, Inc. All rights reserved. US-VBGN-2000042 (v9.0) 04/24

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?
GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information.

What is GEMTESA?

GEMTESA is a prescription medicine for adults used to treat the following symptoms due to a condition called overactive bladder:

  • urge urinary incontinence: a strong need to urinate with leaking or wetting accidents
  • urgency: the need to urinate right away
  • frequency: urinating often

It is not known if GEMTESA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Do not take GEMTESA if you are allergic to vibegron or any of the ingredients in GEMTESA.

Before you take GEMTESA, tell your doctor about all your medical conditions, including if you have liver problems; have kidney problems; have trouble emptying your bladder or you have a weak urine stream; take medicines that contain digoxin; are pregnant or plan to become pregnant (it is not known if GEMTESA will harm your unborn baby; talk to your doctor if you are pregnant or plan to become pregnant); are breastfeeding or plan to breastfeed (it is not known if GEMTESA passes into your breast milk; talk to your doctor about the best way to feed your baby if you take GEMTESA).

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.

What are the possible side effects of GEMTESA?
GEMTESA may cause serious side effects including the inability to empty your bladder (urinary retention). GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder. Tell your doctor right away if you are unable to empty your bladder.

The most common side effects of GEMTESA include headache, urinary tract infection, nasal congestion, sore throat or runny nose, diarrhea, nausea and upper respiratory tract infection. These are not all the possible side effects of GEMTESA. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information.

You are encouraged to report side effects and product complaints associated with GEMTESA by calling 1-833-876-8268.

Sumitomo Pharma logo.

is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO PHARMA is a trademark of Sumitomo Pharma Co., Ltd., used under license. SUMITOMO is a registered trademark of Sumitomo Chemical Co., Ltd., used under license. Sumitomo Pharma America, Inc. is a U.S. subsidiary of Sumitomo Pharma Co., Ltd.

GEMTESA, and the GEMTESA logo are trademarks of Urovant Sciences GmbH, registered in the U.S. and in other countries.

©2024 Sumitomo Pharma America, Inc. All rights reserved. US-VBGN-2000043 (v10.0) 03/24